In addition to the proangiogenic potential we have seen in this CD271+ AD-MSC population, reactome analysis revealed that inflammatory pathways were most significantly changed between CD271+ and CD271− AD-MSCs, suggesting that CD271+ AD-MSCs have anti-inflammatory potential. This evidence concerns the gene NGFR and Alzheimer disease.